about
Aldo-keto Reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugatesEnzymes of the cyclooxygenase pathways of prostanoid biosynthesisAn old NSAID revisited: crystal structure of aldose reductase in complex with sulindac at 1.0 Å supports a novel mechanism for its anticancer and antiproliferative effectsInvolvement of inflammation and its related microRNAs in hepatocellular carcinomaA potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseasesPericellular pH homeostasis is a primary function of the Warburg effect: inversion of metabolic systems to control lactate steady state in tumor cells.Proteomics of muscle chronological ageing in post-menopausal womenPhenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistanceDual-color immunofluorescent labeling with quantum dots of the diabetes-associated proteins aldose reductase and Toll-like receptor 4 in the kidneys of diabetic rats.Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases.Comparison of Integrated Responses to Nonlethal and Lethal Hypothermal Stress in Milkfish (Chanos chanos): A Proteomics Study.Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a.Transcriptome Profiles Using Next-Generation Sequencing Reveal Liver Changes in the Early Stage of Diabetes in Tree Shrew (Tupaia belangeri chinensis)Fructose and uric acid in diabetic nephropathyCaveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis.Aldose reductase mediates endothelial cell dysfunction induced by high uric acid concentrations.The betaine/GABA transporter and betaine: roles in brain, kidney, and liver.Regulation of aldo-keto reductases in human diseases.Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease.Regulation of NF-κB-induced inflammatory signaling by lipid peroxidation-derived aldehydes.Development of aldose reductase inhibitors for the treatment of inflammatory disorders.Aldose Reductase Inhibitor Protects against Hyperglycemic Stress by Activating Nrf2-Dependent Antioxidant ProteinsBlanching influences the phenolics composition, antioxidant activity, and inhibitory effect of Adansonia digitata leaves extract on α-amylase, α-glucosidase, and aldose reductase.Blockage of NOX2/MAPK/NF-κB Pathway Protects Photoreceptors against Glucose Deprivation-Induced Cell DeathProoxidant-antioxidant balance in umbilical cord blood of infants with meconium stained of amniotic fluid.Antidiabetic potential of polyoxotungstates: in vitro and in vivo studies.Prooxidant-antioxidant balance in patients with traumatic brain injury.2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent.Systematic Understanding of the Mechanism of Salvianolic Acid A via Computational Target Fishing.The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10.Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?
P2860
Q24313499-931381AB-997F-442B-84E6-3FB9E9765C9CQ24630614-63A70B3D-329B-4D43-B11B-BFF078A21AC3Q27675028-C11BE079-B70C-4EF4-844E-72DB2914E5F4Q28079138-2FA87E8E-F0D0-497E-8DAF-8256A666BAF1Q28382891-298939A3-3434-4586-A25E-6762578F6C99Q34154991-5008235F-EA56-43EE-BC08-EF86B24FF6D3Q35532444-7B4D1F54-B8C8-4865-9530-B70402547C28Q35569960-336260F0-C757-4939-BAF7-BD9AF099D435Q35654369-05787E44-24D8-41B7-A66E-D0FC89C27BBCQ35825211-AE9C251A-F598-4ED9-BF84-C3F8F0D2C23CQ36141050-EE1B95F3-1D6C-4EF2-9A39-B1E5DA31D544Q36645354-A9B76581-F372-45FE-A421-04F4E53BF8B5Q36741947-CBC2B7A3-E3B9-4333-8C2D-3B3257895998Q36782938-C274B2E2-28DE-49F9-B519-782DCD437970Q37434620-3B376E10-F364-41FC-8D07-B6488EC12A0CQ37566155-D3115AD9-CA66-46FC-863D-6056C2D3F018Q37735049-179031EA-490B-4CCD-9509-516502B7F38CQ37992629-BD90D97C-0DF7-4C95-A90D-740B10FE6B81Q38077549-4326BBB2-229F-4A3D-8BA5-C12F4971A2E3Q38109629-5AE051EA-E2C4-4B07-A373-4E004FFCB444Q38148786-0F9183DF-83D9-442B-8A4C-69071BA7C564Q40979631-B4CBE05F-B97D-4A0E-98C9-3AD7C8265724Q42318971-FED066C3-D9A9-4845-8F45-80B72F0BAE9EQ42729199-2B32B637-2F59-4D84-9960-5F628AB9737CQ42793854-13EAD09B-C787-44B3-A833-D5039F9A6725Q46191421-2493B7EA-9661-48E0-92F4-DDC6BC7A03DFQ46866335-1A108B2C-0464-43B3-962F-C6B1F4EB608FQ50475900-84ACFF0F-4915-4E4A-B5F3-C50E0FB4464DQ51050981-B0A34483-5F80-4E2B-A2C6-2DA73A3182A4Q52658650-D03C1146-288A-47C7-8BEB-4F579B75E855Q52755069-CEACC8A4-57E2-4EF2-932E-4CD7EC100A54Q53244774-FFB3B6CF-AA8F-4276-9915-4E744E0F2BCA
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@ast
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@en
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@nl
type
label
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@ast
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@en
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@nl
prefLabel
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@ast
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@en
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@nl
P2860
P356
P1476
ALDOSE REDUCTASE: New Insights for an Old Enzyme.
@en
P2093
Kota V Ramana
P2860
P304
P356
10.1515/BMC.2011.002
P577
2011-04-01T00:00:00Z